Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern

Steven Y. Gao(Engeneic (Australia)), Himanshu Brahmbhatt(Engeneic (Australia))
Frontiers in Immunology
January 27, 2023
Cited by 6


Related Papers

No related papers found

Powered by citation graph analysis